» Articles » PMID: 27584680

Lead-Related Genetic Loci, Cumulative Lead Exposure and Incident Coronary Heart Disease: The Normative Aging Study

Overview
Journal PLoS One
Date 2016 Sep 2
PMID 27584680
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cumulative exposure to lead is associated with cardiovascular outcomes. Polymorphisms in the δ-aminolevulinic acid dehydratase (ALAD), hemochromatosis (HFE), heme oxygenase-1 (HMOX1), vitamin D receptor (VDR), glutathione S-transferase (GST) supergene family (GSTP1, GSTT1, GSTM1), apolipoprotein E (APOE),angiotensin II receptor-1 (AGTR1) and angiotensinogen (AGT) genes, are believed to alter toxicokinetics and/or toxicodynamics of lead.

Objectives: We assessed possible effect modification by genetic polymorphisms in ALAD, HFE, HMOX1, VDR, GSTP1, GSTT1, GSTM1, APOE, AGTR1 and AGT individually and as the genetic risk score (GRS) on the association between cumulative lead exposure and incident coronary heart disease (CHD) events.

Methods: We used K-shell-X-ray fluorescence to measure bone lead levels. GRS was calculated on the basis of 22 lead-related loci. We constructed Cox proportional hazard models to compute adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for incident CHD. We applied inverse probability weighting to account for potential selection bias due to recruitment into the bone lead sub-study.

Results: Significant effect modification was found by VDR, HMOX1, GSTP1, APOE, and AGT genetic polymorphisms when evaluated individually. Further, the bone lead-CHD associations became larger as GRS increases. After adjusting for potential confounders, a HR of CHD was 2.27 (95%CI: 1.50-3.42) with 2-fold increase in patella lead levels, among participants in the top tertile of GRS. We also detected an increasing trend in HRs across tertiles of GRS (p-trend = 0.0063).

Conclusions: Our findings suggest that lead-related loci as a whole may play an important role in susceptibility to lead-related CHD risk. These findings need to be validated in a separate cohort containing bone lead, lead-related genetic loci and incident CHD data.

Citing Articles

Association between lead and circulating markers of inflammation among traffic enforcers in Metro Manila, Philippines: the MMDA traffic enforcer's health study.

Regencia Z, Zhao W, Torres-Roja C, Jones B, Baja E Int Arch Occup Environ Health. 2024; 97(3):303-311.

PMID: 38351350 DOI: 10.1007/s00420-023-02044-w.


Correlation between ESR1 and APOE gene polymorphisms and risk of osteonecrosis of the femoral head: a case-control study.

Wang Y, Ma X, Guo J, Li Y, Xiong Y J Orthop Surg Res. 2023; 18(1):968.

PMID: 38102657 PMC: 10722694. DOI: 10.1186/s13018-023-04447-4.


ApoE gene polymorphisms and metals and their interactions with cognitive function.

Ye Z, Tan D, Luo T, Gou R, Cai J, Wei Y BMC Med Genomics. 2023; 16(1):206.

PMID: 37644506 PMC: 10466837. DOI: 10.1186/s12920-023-01632-6.


Human Body Burden of Heavy Metals and Health Consequences of Pb Exposure in Guiyu, an E-Waste Recycling Town in China.

Huang W, Shi X, Wu K Int J Environ Res Public Health. 2021; 18(23).

PMID: 34886154 PMC: 8657058. DOI: 10.3390/ijerph182312428.


Short-Term Cumulative Exposure to Ambient Traffic-Related Black Carbon and Blood Pressure: MMDA Traffic Enforcers' Health Study.

Regencia Z, Dalmacion G, Ligsay A, Baja E Int J Environ Res Public Health. 2021; 18(22).

PMID: 34831878 PMC: 8619089. DOI: 10.3390/ijerph182212122.


References
1.
Zhang A, Park S, Wright R, Weisskopf M, Mukherjee B, Nie H . HFE H63D polymorphism as a modifier of the effect of cumulative lead exposure on pulse pressure: the Normative Aging Study. Environ Health Perspect. 2010; 118(9):1261-6. PMC: 2944087. DOI: 10.1289/ehp.1002251. View

2.
Waheed A, Parkkila S, Zhou X, Tomatsu S, Tsuchihashi Z, Feder J . Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci U S A. 1997; 94(23):12384-9. PMC: 24956. DOI: 10.1073/pnas.94.23.12384. View

3.
Haynes E, Kalkwarf H, Hornung R, Wenstrup R, Dietrich K, Lanphear B . Vitamin D receptor Fok1 polymorphism and blood lead concentration in children. Environ Health Perspect. 2003; 111(13):1665-9. PMC: 1241691. DOI: 10.1289/ehp.6167. View

4.
Li Y, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J . Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol. 2004; 89-90(1-5):387-92. DOI: 10.1016/j.jsbmb.2004.03.004. View

5.
Hu H, Aro A, Rotnitzky A . Bone lead measured by X-ray fluorescence: epidemiologic methods. Environ Health Perspect. 1995; 103 Suppl 1:105-10. PMC: 1519344. DOI: 10.1289/ehp.95103s1105. View